http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.
변환된 중국어를 복사하여 사용하시면 됩니다.
- 中文 을 입력하시려면 zhongwen을 입력하시고 space를누르시면됩니다.
- 北京 을 입력하시려면 beijing을 입력하시고 space를 누르시면 됩니다.
RISS 인기검색어
- 검색키워드
- 저자 : Hyosung Maeng (검색결과 1 건)
- 무료
- 기관 내 무료
- 유료
-
초기 신생혈관 녹내장에서 Bevacizumab (Avastin®)를 이용한 치료 1예
맹효성,김진철,기창원,Hyosung Maeng,M,D,Jinchul Kim,M,D,Changwon Kee,M,D,Ph,D 대한안과학회 2008 대한안과학회지 Vol.49 No.4
Purpose: This case is conducted to assess the short‐term safety and efficacy of intravitreal bevacizumab injection in patient with early‐stage of the neovascular glaucoma (NVG) without peripheral anterior synechiae. Case summary: A 66‐year‐old patient with a history of proliferative diabetic retinopathy presented with neovascularization of the iris and the angle and high intraocular pressure of 30 mmHg. The patient received a single injection of bevacizumab (1.25 mg /0.05 mg) intravitreally. The visual acuity (VA), intraocular pressure (IOP), regression of the iris and the angle neovascularization were measured up to the twenty ninth week after injection. Regression of the iris and angle neovascularization were confirmed from the second week after injection. The visual acuity had continued stable and the IOP had been controlled from 30 mmHg to 20 mmHg from fifth week without the need for topical antiglaucoma medications until the twenty ninth week. Conclusions: Bevacizumab may be an effective medication for the treatment of neovascular glaucoma. Bevacizumab seems to be a useful adjunct or an advantageous treatment option to panretinal photocoagulation in the treatment of neovascular glaucoma.
KCI
스콜라연관 검색어 추천
이 검색어로 많이 본 자료
활용도 높은 자료
